APO Research

APO RESEARCH · REPORT

Veterinary Antibacterial Prescription Drugs

Selected research

Industry Growth & Trends

Global Veterinary Antibacterial Prescription Drugs Industry Growth and Trends Forecast to 2032

Market perspective

The global Veterinary Antibacterial Prescription Drugs market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Veterinary Antibacterial Prescription Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Veterinary Antibacterial Prescription Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Veterinary Antibacterial Prescription Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Veterinary Antibacterial Prescription Drugs include China Animal Health And Resource, Zoetis, Shandong Lukang Shelile Pharmaceutical, Ripud Biotech, Qilu Pharmaceutical, North China Pharmaceutical, Dalian Sanyi Animal Pharmaceutical, ZyVet and Virbac, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Veterinary Antibacterial Prescription Drugs market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Veterinary Antibacterial Prescription Drugs market size, estimates, and forecasts are presented in terms of sales volume (units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Veterinary Antibacterial Prescription Drugs market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Veterinary Antibacterial Prescription Drugs.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Veterinary Antibacterial Prescription Drugs market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Veterinary Antibacterial Prescription Drugs Market by Company

China Animal Health And Resource

Zoetis

Shandong Lukang Shelile Pharmaceutical

Ripud Biotech

Qilu Pharmaceutical

North China Pharmaceutical

Dalian Sanyi Animal Pharmaceutical

ZyVet

Virbac

Vetoquinol

Randolph And Scott

Pharmaq

PetMed Express

Norbrook Laboratories

Merial

Merck Animal Health

Heska

Elanco Animal Health

Dechra Pharmaceuticals

Ceva Sante Animale

Boehringer Ingelheim Animal Health

Veterinary Antibacterial Prescription Drugs Segment by Type

Beta-Lactams

Aminoglycosides

Macrolides

Fluoroquinolones

Sulphonamides

Tetracyclines

Others

Veterinary Antibacterial Prescription Drugs Segment by Application

Animal Medicine Research

Animal Husbandry

Pet Medical

Others

Veterinary Antibacterial Prescription Drugs Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Veterinary Antibacterial Prescription Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Veterinary Antibacterial Prescription Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Veterinary Antibacterial Prescription Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Veterinary Antibacterial Prescription Drugs manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Veterinary Antibacterial Prescription Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Beta-Lactams Table 2. Major Company of Aminoglycosides Table 3. Major Company of Macrolides Table 4. Major Company of Fluoroquinolones Table 5. Major Company of Sulphonamides Table 6. Major Company of Tetracyclines Table 7. Major Company of Others Table 8. Global Veterinary Antibacterial Prescription Drugs Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 9. Global Veterinary Antibacterial Prescription Drugs Sales by Type (2021-2026) & (units) Table 10. Global Veterinary Antibacterial Prescription Drugs Sales Market Share in Volume by Type (2021-2026) Table 11. Global Veterinary Antibacterial Prescription Drugs Sales by Type (2021-2026) & (US$ Million) Table 12. Global Veterinary Antibacterial Prescription Drugs Sales Market Share in Value by Type (2021-2026) Table 13. Global Veterinary Antibacterial Prescription Drugs Price by Type (2021-2026) & (USD/unit) Table 14. Global Veterinary Antibacterial Prescription Drugs Sales by Type (2027-2032) & (units) Table 15. Global Veterinary Antibacterial Prescription Drugs Sales Market Share in Volume by Type (2027-2032) Table 16. Global Veterinary Antibacterial Prescription Drugs Sales by Type (2027-2032) & (US$ Million) Table 17. Global Veterinary Antibacterial Prescription Drugs Sales Market Share in Value by Type (2027-2032) Table 18. Global Veterinary Antibacterial Prescription Drugs Price by Type (2027-2032) & (USD/unit) Table 19. North America Veterinary Antibacterial Prescription Drugs Sales by Type (2021-2026) & (units) Table 20. North America Veterinary Antibacterial Prescription Drugs Sales by Type (2021-2026) & (US$ Million) Table 21. Europe Veterinary Antibacterial Prescription Drugs Sales by Type (2021-2026) & (units) Table 22. Europe Veterinary Antibacterial Prescription Drugs Sales by Type (2021-2026) & (US$ Million) Table 23. Asia-Pacific Veterinary Antibacterial Prescription Drugs Sales by Type (2021-2026) & (units) Table 24. Asia-Pacific Veterinary Antibacterial Prescription Drugs Sales by Type (2021-2026) & (US$ Million) Table 25. Latin America Veterinary Antibacterial Prescription Drugs Sales by Type (2021-2026) & (units) Table 26. Latin America Veterinary Antibacterial Prescription Drugs Sales by Type (2021-2026) & (US$ Million) Table 27. Middle East and Africa Veterinary Antibacterial Prescription Drugs Sales by Type (2021-2026) & (units) Table 28. Middle East and Africa Veterinary Antibacterial Prescription Drugs Sales by Type (2021-2026) & (US$ Million) Table 29. Veterinary Antibacterial Prescription Drugs Industry Trends Table 30. Veterinary Antibacterial Prescription Drugs Industry Drivers Table 31. Veterinary Antibacterial Prescription Drugs Industry Opportunities and Challenges Table 32. Veterinary Antibacterial Prescription Drugs Industry Restraints Table 33. Global Veterinary Antibacterial Prescription Drugs Sales Revenue by Company (US$ Million) & (2021-2026) Table 34. Global Veterinary Antibacterial Prescription Drugs Revenue Market Share by Company (2021-2026) Table 35. Global Veterinary Antibacterial Prescription Drugs Sales by Company (2021-2026) & (units) Table 36. Global Veterinary Antibacterial Prescription Drugs Sales Share by Company (2021-2026) Table 37. Global Veterinary Antibacterial Prescription Drugs Market Price by Company (2021-2026) & (USD/unit) Table 38. Global Veterinary Antibacterial Prescription Drugs Industry Company Ranking, 2024 VS 2025 VS 2026 Table 39. Global Veterinary Antibacterial Prescription Drugs Major Company Production Sites and Headquarters Table 40. Global Veterinary Antibacterial Prescription Drugs Company, Product Type & Application Table 41. Global Veterinary Antibacterial Prescription Drugs Company Establishment Date Table 42. Global Company Market Concentration Ratio (CR5 and HHI) Table 43. Global Veterinary Antibacterial Prescription Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 44. Global Veterinary Antibacterial Prescription Drugs Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 45. Global Veterinary Antibacterial Prescription Drugs Sales by Region (2021-2026) & (units) Table 46. Global Veterinary Antibacterial Prescription Drugs Sales Market Share in Volume by Region (2021-2026) Table 47. Global Veterinary Antibacterial Prescription Drugs Sales by Region (2021-2026) & (US$ Million) Table 48. Global Veterinary Antibacterial Prescription Drugs Sales Market Share in Value by Region (2021-2026) Table 49. Global Veterinary Antibacterial Prescription Drugs Sales (units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 50. Global Veterinary Antibacterial Prescription Drugs Sales by Region (2027-2032) & (units) Table 51. Global Veterinary Antibacterial Prescription Drugs Sales Market Share in Volume by Region (2027-2032) Table 52. Global Veterinary Antibacterial Prescription Drugs Sales by Region (2027-2032) & (US$ Million) Table 53. Global Veterinary Antibacterial Prescription Drugs Sales Market Share in Value by Region (2027-2032) Table 54. Global Veterinary Antibacterial Prescription Drugs Sales (units), Value (US$ Million), Price (USD/unit) and Gross Margin (2027-2032) Table 55. Global Veterinary Antibacterial Prescription Drugs Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 56. Global Veterinary Antibacterial Prescription Drugs Sales by Application (2021-2026) & (units) Table 57. Global Veterinary Antibacterial Prescription Drugs Sales Market Share in Volume by Application (2021-2026) Table 58. Global Veterinary Antibacterial Prescription Drugs Sales by Application (2021-2026) & (US$ Million) Table 59. Global Veterinary Antibacterial Prescription Drugs Sales Market Share in Value by Application (2021-2026) Table 60. Global Veterinary Antibacterial Prescription Drugs Price by Application (2021-2026) & (USD/unit) Table 61. Global Veterinary Antibacterial Prescription Drugs Sales by Application (2027-2032) & (units) Table 62. Global Veterinary Antibacterial Prescription Drugs Sales Market Share in Volume by Application (2027-2032) Table 63. Global Veterinary Antibacterial Prescription Drugs Sales by Application (2027-2032) & (US$ Million) Table 64. Global Veterinary Antibacterial Prescription Drugs Sales Market Share in Value by Application (2027-2032) Table 65. Global Veterinary Antibacterial Prescription Drugs Price by Application (2027-2032) & (USD/unit) Table 66. North America Veterinary Antibacterial Prescription Drugs Sales by Application (2021-2026) & (units) Table 67. North America Veterinary Antibacterial Prescription Drugs Sales by Application (2021-2026) & (US$ Million) Table 68. Europe Veterinary Antibacterial Prescription Drugs Sales by Application (2021-2026) & (units) Table 69. Europe Veterinary Antibacterial Prescription Drugs Sales by Application (2021-2026) & (US$ Million) Table 70. Asia-Pacific Veterinary Antibacterial Prescription Drugs Sales by Application (2021-2026) & (units) Table 71. Asia-Pacific Veterinary Antibacterial Prescription Drugs Sales by Application (2021-2026) & (US$ Million) Table 72. Latin America Veterinary Antibacterial Prescription Drugs Sales by Application (2021-2026) & (units) Table 73. Latin America Veterinary Antibacterial Prescription Drugs Sales by Application (2021-2026) & (US$ Million) Table 74. Middle East and Africa Veterinary Antibacterial Prescription Drugs Sales by Application (2021-2026) & (units) Table 75. Middle East and Africa Veterinary Antibacterial Prescription Drugs Sales by Application (2021-2026) & (US$ Million) Table 76. China Animal Health And Resource Company Information Table 77. China Animal Health And Resource Business Overview Table 78. China Animal Health And Resource Veterinary Antibacterial Prescription Drugs Sales (units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 79. China Animal Health And Resource Veterinary Antibacterial Prescription Drugs Product Portfolio Table 80. China Animal Health And Resource Recent Development Table 81. Zoetis Company Information Table 82. Zoetis Business Overview Table 83. Zoetis Veterinary Antibacterial Prescription Drugs Sales (units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 84. Zoetis Veterinary Antibacterial Prescription Drugs Product Portfolio Table 85. Zoetis Recent Development Table 86. Shandong Lukang Shelile Pharmaceutical Company Information Table 87. Shandong Lukang Shelile Pharmaceutical Business Overview Table 88. Shandong Lukang Shelile Pharmaceutical Veterinary Antibacterial Prescription Drugs Sales (units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 89. Shandong Lukang Shelile Pharmaceutical Veterinary Antibacterial Prescription Drugs Product Portfolio Table 90. Shandong Lukang Shelile Pharmaceutical Recent Development Table 91. Ripud Biotech Company Information Table 92. Ripud Biotech Business Overview Table 93. Ripud Biotech Veterinary Antibacterial Prescription Drugs Sales (units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 94. Ripud Biotech Veterinary Antibacterial Prescription Drugs Product Portfolio Table 95. Ripud Biotech Recent Development Table 96. Qilu Pharmaceutical Company Information Table 97. Qilu Pharmaceutical Business Overview Table 98. Qilu Pharmaceutical Veterinary Antibacterial Prescription Drugs Sales (units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 99. Qilu Pharmaceutical Veterinary Antibacterial Prescription Drugs Product Portfolio Table 100. Qilu Pharmaceutical Recent Development Table 101. North China Pharmaceutical Company Information Table 102. North China Pharmaceutical Business Overview Table 103. North China Pharmaceutical Veterinary Antibacterial Prescription Drugs Sales (units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 104. North China Pharmaceutical Veterinary Antibacterial Prescription Drugs Product Portfolio Table 105. North China Pharmaceutical Recent Development Table 106. Dalian Sanyi Animal Pharmaceutical Company Information Table 107. Dalian Sanyi Animal Pharmaceutical Business Overview Table 108. Dalian Sanyi Animal Pharmaceutical Veterinary Antibacterial Prescription Drugs Sales (units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 109. Dalian Sanyi Animal Pharmaceutical Veterinary Antibacterial Prescription Drugs Product Portfolio Table 110. Dalian Sanyi Animal Pharmaceutical Recent Development Table 111. ZyVet Company Information Table 112. ZyVet Business Overview Table 113. ZyVet Veterinary Antibacterial Prescription Drugs Sales (units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 114. ZyVet Veterinary Antibacterial Prescription Drugs Product Portfolio Table 115. ZyVet Recent Development Table 116. Virbac Company Information Table 117. Virbac Business Overview Table 118. Virbac Veterinary Antibacterial Prescription Drugs Sales (units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 119. Virbac Veterinary Antibacterial Prescription Drugs Product Portfolio Table 120. Virbac Recent Development Table 121. Vetoquinol Company Information Table 122. Vetoquinol Business Overview Table 123. Vetoquinol Veterinary Antibacterial Prescription Drugs Sales (units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 124. Vetoquinol Veterinary Antibacterial Prescription Drugs Product Portfolio Table 125. Vetoquinol Recent Development Table 126. Randolph And Scott Company Information Table 127. Randolph And Scott Business Overview Table 128. Randolph And Scott Veterinary Antibacterial Prescription Drugs Sales (units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 129. Randolph And Scott Veterinary Antibacterial Prescription Drugs Product Portfolio Table 130. Randolph And Scott Recent Development Table 131. Pharmaq Company Information Table 132. Pharmaq Business Overview Table 133. Pharmaq Veterinary Antibacterial Prescription Drugs Sales (units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 134. Pharmaq Veterinary Antibacterial Prescription Drugs Product Portfolio Table 135. Pharmaq Recent Development Table 136. PetMed Express Company Information Table 137. PetMed Express Business Overview Table 138. PetMed Express Veterinary Antibacterial Prescription Drugs Sales (units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 139. PetMed Express Veterinary Antibacterial Prescription Drugs Product Portfolio Table 140. PetMed Express Recent Development Table 141. Norbrook Laboratories Company Information Table 142. Norbrook Laboratories Business Overview Table 143. Norbrook Laboratories Veterinary Antibacterial Prescription Drugs Sales (units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 144. Norbrook Laboratories Veterinary Antibacterial Prescription Drugs Product Portfolio Table 145. Norbrook Laboratories Recent Development Table 146. Merial Company Information Table 147. Merial Business Overview Table 148. Merial Veterinary Antibacterial Prescription Drugs Sales (units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 149. Merial Veterinary Antibacterial Prescription Drugs Product Portfolio Table 150. Merial Recent Development Table 151. Merck Animal Health Company Information Table 152. Merck Animal Health Business Overview Table 153. Merck Animal Health Veterinary Antibacterial Prescription Drugs Sales (units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 154. Merck Animal Health Veterinary Antibacterial Prescription Drugs Product Portfolio Table 155. Merck Animal Health Recent Development Table 156. Heska Company Information Table 157. Heska Business Overview Table 158. Heska Veterinary Antibacterial Prescription Drugs Sales (units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 159. Heska Veterinary Antibacterial Prescription Drugs Product Portfolio Table 160. Heska Recent Development Table 161. Elanco Animal Health Company Information Table 162. Elanco Animal Health Business Overview Table 163. Elanco Animal Health Veterinary Antibacterial Prescription Drugs Sales (units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 164. Elanco Animal Health Veterinary Antibacterial Prescription Drugs Product Portfolio Table 165. Elanco Animal Health Recent Development Table 166. Dechra Pharmaceuticals Company Information Table 167. Dechra Pharmaceuticals Business Overview Table 168. Dechra Pharmaceuticals Veterinary Antibacterial Prescription Drugs Sales (units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 169. Dechra Pharmaceuticals Veterinary Antibacterial Prescription Drugs Product Portfolio Table 170. Dechra Pharmaceuticals Recent Development Table 171. Ceva Sante Animale Company Information Table 172. Ceva Sante Animale Business Overview Table 173. Ceva Sante Animale Veterinary Antibacterial Prescription Drugs Sales (units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 174. Ceva Sante Animale Veterinary Antibacterial Prescription Drugs Product Portfolio Table 175. Ceva Sante Animale Recent Development Table 176. Boehringer Ingelheim Animal Health Company Information Table 177. Boehringer Ingelheim Animal Health Business Overview Table 178. Boehringer Ingelheim Animal Health Veterinary Antibacterial Prescription Drugs Sales (units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 179. Boehringer Ingelheim Animal Health Veterinary Antibacterial Prescription Drugs Product Portfolio Table 180. Boehringer Ingelheim Animal Health Recent Development Table 181. North America Veterinary Antibacterial Prescription Drugs Market Size Growth Rate (CAGR) by Country (units): 2021 VS 2025 VS 2032 Table 182. North America Veterinary Antibacterial Prescription Drugs Sales by Country (2021-2026) & (units) Table 183. North America Veterinary Antibacterial Prescription Drugs Sales Market Share by Country (2021-2026) Table 184. North America Veterinary Antibacterial Prescription Drugs Sales Forecast by Country (2027-2032) & (units) Table 185. North America Veterinary Antibacterial Prescription Drugs Sales Market Share Forecast by Country (2027-2032) Table 186. North America Veterinary Antibacterial Prescription Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 187. North America Veterinary Antibacterial Prescription Drugs Market Size by Country (2021-2026) & (US$ Million) Table 188. North America Veterinary Antibacterial Prescription Drugs Market Share by Country (2021-2026) Table 189. North America Veterinary Antibacterial Prescription Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 190. North America Veterinary Antibacterial Prescription Drugs Market Share Forecast by Country (2027-2032) Table 191. Europe Veterinary Antibacterial Prescription Drugs Market Size Growth Rate (CAGR) by Country (units): 2021 VS 2025 VS 2032 Table 192. Europe Veterinary Antibacterial Prescription Drugs Sales by Country (2021-2026) & (units) Table 193. Europe Veterinary Antibacterial Prescription Drugs Sales Market Share by Country (2021-2026) Table 194. Europe Veterinary Antibacterial Prescription Drugs Sales Forecast by Country (2027-2032) & (units) Table 195. Europe Veterinary Antibacterial Prescription Drugs Sales Market Share Forecast by Country (2027-2032) Table 196. Europe Veterinary Antibacterial Prescription Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 197. Europe Veterinary Antibacterial Prescription Drugs Market Size by Country (2021-2026) & (US$ Million) Table 198. Europe Veterinary Antibacterial Prescription Drugs Market Share by Country (2021-2026) Table 199. Europe Veterinary Antibacterial Prescription Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 200. Europe Veterinary Antibacterial Prescription Drugs Market Share Forecast by Country (2027-2032) Table 201. Asia-Pacific Veterinary Antibacterial Prescription Drugs Market Size Growth Rate (CAGR) by Country (units): 2021 VS 2025 VS 2032 Table 202. Asia-Pacific Veterinary Antibacterial Prescription Drugs Sales by Country (2021-2026) & (units) Table 203. Asia-Pacific Veterinary Antibacterial Prescription Drugs Sales Market Share by Country (2021-2026) Table 204. Asia-Pacific Veterinary Antibacterial Prescription Drugs Sales Forecast by Country (2027-2032) & (units) Table 205. Asia-Pacific Veterinary Antibacterial Prescription Drugs Sales Market Share Forecast by Country (2027-2032) Table 206. Asia-Pacific Veterinary Antibacterial Prescription Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 207. Asia-Pacific Veterinary Antibacterial Prescription Drugs Market Size by Country (2021-2026) & (US$ Million) Table 208. Asia-Pacific Veterinary Antibacterial Prescription Drugs Market Share by Country (2021-2026) Table 209. Asia-Pacific Veterinary Antibacterial Prescription Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 210. Asia-Pacific Veterinary Antibacterial Prescription Drugs Market Share Forecast by Country (2027-2032) Table 211. Latin America Veterinary Antibacterial Prescription Drugs Market Size Growth Rate (CAGR) by Country (units): 2021 VS 2025 VS 2032 Table 212. Latin America Veterinary Antibacterial Prescription Drugs Sales by Country (2021-2026) & (units) Table 213. Latin America Veterinary Antibacterial Prescription Drugs Sales Market Share by Country (2021-2026) Table 214. Latin America Veterinary Antibacterial Prescription Drugs Sales Forecast by Country (2027-2032) & (units) Table 215. Latin America Veterinary Antibacterial Prescription Drugs Sales Market Share Forecast by Country (2027-2032) Table 216. Latin America Veterinary Antibacterial Prescription Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 217. Latin America Veterinary Antibacterial Prescription Drugs Market Size by Country (2021-2026) & (US$ Million) Table 218. Latin America Veterinary Antibacterial Prescription Drugs Market Share by Country (2021-2026) Table 219. Latin America Veterinary Antibacterial Prescription Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 220. Latin America Veterinary Antibacterial Prescription Drugs Market Share Forecast by Country (2027-2032) Table 221. Middle East and Africa Veterinary Antibacterial Prescription Drugs Market Size Growth Rate (CAGR) by Country (units): 2021 VS 2025 VS 2032 Table 222. Middle East and Africa Veterinary Antibacterial Prescription Drugs Sales by Country (2021-2026) & (units) Table 223. Middle East and Africa Veterinary Antibacterial Prescription Drugs Sales Market Share by Country (2021-2026) Table 224. Middle East and Africa Veterinary Antibacterial Prescription Drugs Sales Forecast by Country (2027-2032) & (units) Table 225. Middle East and Africa Veterinary Antibacterial Prescription Drugs Sales Market Share Forecast by Country (2027-2032) Table 226. Middle East and Africa Veterinary Antibacterial Prescription Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 227. Middle East and Africa Veterinary Antibacterial Prescription Drugs Market Size by Country (2021-2026) & (US$ Million) Table 228. Middle East and Africa Veterinary Antibacterial Prescription Drugs Market Share by Country (2021-2026) Table 229. Middle East and Africa Veterinary Antibacterial Prescription Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 230. Middle East and Africa Veterinary Antibacterial Prescription Drugs Market Share Forecast by Country (2027-2032) Table 231. Key Raw Materials Table 232. Raw Materials Key Suppliers Table 233. Veterinary Antibacterial Prescription Drugs Distributors List Table 234. Veterinary Antibacterial Prescription Drugs Customers List Table 235. Research Programs/Design for This Report Table 236. Authors List of This Report Table 237. Secondary Sources Table 238. Primary Sources List of Figures Figure 1. Veterinary Antibacterial Prescription Drugs Image Figure 2. Global Veterinary Antibacterial Prescription Drugs Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Veterinary Antibacterial Prescription Drugs Market Size (2021-2032) & (US$ Million) Figure 4. Global Veterinary Antibacterial Prescription Drugs Sales (2021-2032) & (units) Figure 5. Beta-Lactams Image Figure 6. Global Beta-Lactams Sales YoY Growth (2021-2032) & (units) Figure 7. Aminoglycosides Image Figure 8. Global Aminoglycosides Sales YoY Growth (2021-2032) & (units) Figure 9. Macrolides Image Figure 10. Global Macrolides Sales YoY Growth (2021-2032) & (units) Figure 11. Fluoroquinolones Image Figure 12. Global Fluoroquinolones Sales YoY Growth (2021-2032) & (units) Figure 13. Sulphonamides Image Figure 14. Global Sulphonamides Sales YoY Growth (2021-2032) & (units) Figure 15. Tetracyclines Image Figure 16. Global Tetracyclines Sales YoY Growth (2021-2032) & (units) Figure 17. Others Image Figure 18. Global Others Sales YoY Growth (2021-2032) & (units) Figure 19. Global Veterinary Antibacterial Prescription Drugs Market Size Overview by Type (2021-2032) & (US$ Million) Figure 20. Global Veterinary Antibacterial Prescription Drugs Market Share by Type 2025 VS 2032 Figure 21. North America Veterinary Antibacterial Prescription Drugs Sales Market Share in Volume by Type in 2025 Figure 22. North America Veterinary Antibacterial Prescription Drugs Sales Market Share in Value by Type in 2025 Figure 23. Europe Veterinary Antibacterial Prescription Drugs Sales Market Share in Volume by Type in 2025 Figure 24. Europe Veterinary Antibacterial Prescription Drugs Sales Market Share in Value by Type in 2025 Figure 25. Asia-Pacific Veterinary Antibacterial Prescription Drugs Sales Market Share in Volume by Type in 2025 Figure 26. Asia-Pacific Veterinary Antibacterial Prescription Drugs Sales Market Share in Value by Type in 2025 Figure 27. Latin America Veterinary Antibacterial Prescription Drugs Sales Market Share in Volume by Type in 2025 Figure 28. Latin America Veterinary Antibacterial Prescription Drugs Sales Market Share in Value by Type in 2025 Figure 29. Middle East and Africa Veterinary Antibacterial Prescription Drugs Sales Market Share in Volume by Type in 2025 Figure 30. Middle East and Africa Veterinary Antibacterial Prescription Drugs Sales Market Share in Value by Type in 2025 Figure 31. Global Top 5 and 10 Veterinary Antibacterial Prescription Drugs Players Market Share by Revenue in 2025 Figure 32. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 33. Animal Medicine Research Image Figure 34. Global Animal Medicine Research Sales YoY Growth (2021-2032) & (units) Figure 35. Animal Husbandry Image Figure 36. Global Animal Husbandry Sales YoY Growth (2021-2032) & (units) Figure 37. Pet Medical Image Figure 38. Global Pet Medical Sales YoY Growth (2021-2032) & (units) Figure 39. Others Image Figure 40. Global Others Sales YoY Growth (2021-2032) & (units) Figure 41. Global Veterinary Antibacterial Prescription Drugs Market Size Overview by Application (2021-2032) & (US$ Million) Figure 42. Global Veterinary Antibacterial Prescription Drugs Market Share by Application 2025 VS 2032 Figure 43. North America Veterinary Antibacterial Prescription Drugs Sales Market Share in Volume by Application in 2025 Figure 44. North America Veterinary Antibacterial Prescription Drugs Sales Market Share in Value by Application in 2025 Figure 45. Europe Veterinary Antibacterial Prescription Drugs Sales Market Share in Volume by Application in 2025 Figure 46. Europe Veterinary Antibacterial Prescription Drugs Sales Market Share in Value by Application in 2025 Figure 47. Asia-Pacific Veterinary Antibacterial Prescription Drugs Sales Market Share in Volume by Application in 2025 Figure 48. Asia-Pacific Veterinary Antibacterial Prescription Drugs Sales Market Share in Value by Application in 2025 Figure 49. Latin America Veterinary Antibacterial Prescription Drugs Sales Market Share in Volume by Application in 2025 Figure 50. Latin America Veterinary Antibacterial Prescription Drugs Sales Market Share in Value by Application in 2025 Figure 51. Middle East and Africa Veterinary Antibacterial Prescription Drugs Sales Market Share in Volume by Application in 2025 Figure 52. Middle East and Africa Veterinary Antibacterial Prescription Drugs Sales Market Share in Value by Application in 2025 Figure 53. North America Veterinary Antibacterial Prescription Drugs Sales by Country: 2021 VS 2025 VS 2032 (units) Figure 54. North America Veterinary Antibacterial Prescription Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. North America Veterinary Antibacterial Prescription Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. North America Veterinary Antibacterial Prescription Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Europe Veterinary Antibacterial Prescription Drugs Sales by Country: 2021 VS 2025 VS 2032 (units) Figure 58. Europe Veterinary Antibacterial Prescription Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Europe Veterinary Antibacterial Prescription Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Europe Veterinary Antibacterial Prescription Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Asia-Pacific Veterinary Antibacterial Prescription Drugs Sales by Country: 2021 VS 2025 VS 2032 (units) Figure 62. Asia-Pacific Veterinary Antibacterial Prescription Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 63. Asia-Pacific Veterinary Antibacterial Prescription Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 64. Asia-Pacific Veterinary Antibacterial Prescription Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 65. Latin America Veterinary Antibacterial Prescription Drugs Sales by Country: 2021 VS 2025 VS 2032 (units) Figure 66. Latin America Veterinary Antibacterial Prescription Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 67. Latin America Veterinary Antibacterial Prescription Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 68. Latin America Veterinary Antibacterial Prescription Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 69. Middle East and Africa Veterinary Antibacterial Prescription Drugs Sales by Country: 2021 VS 2025 VS 2032 (units) Figure 70. Middle East and Africa Veterinary Antibacterial Prescription Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 71. Middle East and Africa Veterinary Antibacterial Prescription Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 72. Middle East and Africa Veterinary Antibacterial Prescription Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 73. Veterinary Antibacterial Prescription Drugs Value Chain Figure 74. Key Raw Materials Price Figure 75. Manufacturing Cost Structure Figure 76. Veterinary Antibacterial Prescription Drugs Production Mode & Process Figure 77. Direct Comparison with Distribution Share Figure 78. Distributors Profiles Figure 79. Years Considered Figure 80. Research Process Figure 81. Key Executives Interviewed

Scope & coverage.

Types
  • Beta-Lactams
  • Aminoglycosides
  • Macrolides
  • Fluoroquinolones
  • Sulphonamides
  • Tetracyclines
  • Others
Applications
  • Animal Medicine Research
  • Animal Husbandry
  • Pet Medical
  • Others
Companies covered
  • China Animal Health And Resource
  • Zoetis
  • Shandong Lukang Shelile Pharmaceutical
  • Ripud Biotech
  • Qilu Pharmaceutical
  • North China Pharmaceutical
  • Dalian Sanyi Animal Pharmaceutical
  • ZyVet
  • Virbac
  • Vetoquinol
  • Randolph And Scott
  • Pharmaq
  • PetMed Express
  • Norbrook Laboratories
  • Merial
  • Merck Animal Health
  • Heska
  • Elanco Animal Health
  • Dechra Pharmaceuticals
  • Ceva Sante Animale
  • Boehringer Ingelheim Animal Health

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Veterinary Antibacterial Prescription Drugs Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Veterinary Antibacterial Prescription Drugs Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Veterinary Antibacterial Prescription Drugs Market by Type
  6. 1.3.1 Beta-Lactams
  7. 1.3.2 Aminoglycosides
  8. 1.3.3 Macrolides
  9. 1.3.4 Fluoroquinolones
  10. 1.3.5 Sulphonamides
  11. 1.3.6 Tetracyclines
  12. 1.3.7 Others
  13. 1.4 Global Veterinary Antibacterial Prescription Drugs Market Size by Type
  14. 1.4.1 Global Veterinary Antibacterial Prescription Drugs Market Size Overview by Type (2021-2032)
  15. 1.4.2 Global Veterinary Antibacterial Prescription Drugs Historic Market Size Review by Type (2021-2026)
  16. 1.4.3 Global Veterinary Antibacterial Prescription Drugs Forecasted Market Size by Type (2027-2032)
  17. 1.5 Key Regions Market Size by Type
  18. 1.5.1 North America Veterinary Antibacterial Prescription Drugs Sales Breakdown by Type (2021-2026)
  19. 1.5.2 Europe Veterinary Antibacterial Prescription Drugs Sales Breakdown by Type (2021-2026)
  20. 1.5.3 Asia-Pacific Veterinary Antibacterial Prescription Drugs Sales Breakdown by Type (2021-2026)
  21. 1.5.4 South America Veterinary Antibacterial Prescription Drugs Sales Breakdown by Type (2021-2026)
  22. 1.5.5 Middle East and Africa Veterinary Antibacterial Prescription Drugs Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Veterinary Antibacterial Prescription Drugs Industry Trends
  2. 2.2 Veterinary Antibacterial Prescription Drugs Industry Drivers
  3. 2.3 Veterinary Antibacterial Prescription Drugs Industry Opportunities and Challenges
  4. 2.4 Veterinary Antibacterial Prescription Drugs Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Veterinary Antibacterial Prescription Drugs Revenue (2021-2026)
  2. 3.2 Global Top Players by Veterinary Antibacterial Prescription Drugs Sales (2021-2026)
  3. 3.3 Global Top Players by Veterinary Antibacterial Prescription Drugs Price (2021-2026)
  4. 3.4 Global Veterinary Antibacterial Prescription Drugs Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Veterinary Antibacterial Prescription Drugs Major Company Production Sites & Headquarters
  6. 3.6 Global Veterinary Antibacterial Prescription Drugs Company, Product Type & Application
  7. 3.7 Global Veterinary Antibacterial Prescription Drugs Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Veterinary Antibacterial Prescription Drugs Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Veterinary Antibacterial Prescription Drugs Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Veterinary Antibacterial Prescription Drugs Tier 1, Tier 2, and Tier 3
4 Veterinary Antibacterial Prescription Drugs Regional Status and Outlook
  1. 4.1 Global Veterinary Antibacterial Prescription Drugs Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Veterinary Antibacterial Prescription Drugs Historic Market Size by Region
  3. 4.2.1 Global Veterinary Antibacterial Prescription Drugs Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Veterinary Antibacterial Prescription Drugs Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Veterinary Antibacterial Prescription Drugs Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Veterinary Antibacterial Prescription Drugs Forecasted Market Size by Region
  7. 4.3.1 Global Veterinary Antibacterial Prescription Drugs Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Veterinary Antibacterial Prescription Drugs Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Veterinary Antibacterial Prescription Drugs Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Veterinary Antibacterial Prescription Drugs by Application
  1. 5.1 Veterinary Antibacterial Prescription Drugs Market by Application
  2. 5.1.1 Animal Medicine Research
  3. 5.1.2 Animal Husbandry
  4. 5.1.3 Pet Medical
  5. 5.1.4 Others
  6. 5.2 Global Veterinary Antibacterial Prescription Drugs Market Size by Application
  7. 5.2.1 Global Veterinary Antibacterial Prescription Drugs Market Size Overview by Application (2021-2032)
  8. 5.2.2 Global Veterinary Antibacterial Prescription Drugs Historic Market Size Review by Application (2021-2026)
  9. 5.2.3 Global Veterinary Antibacterial Prescription Drugs Forecasted Market Size by Application (2027-2032)
  10. 5.3 Key Regions Market Size by Application
  11. 5.3.1 North America Veterinary Antibacterial Prescription Drugs Sales Breakdown by Application (2021-2026)
  12. 5.3.2 Europe Veterinary Antibacterial Prescription Drugs Sales Breakdown by Application (2021-2026)
  13. 5.3.3 Asia-Pacific Veterinary Antibacterial Prescription Drugs Sales Breakdown by Application (2021-2026)
  14. 5.3.4 South America Veterinary Antibacterial Prescription Drugs Sales Breakdown by Application (2021-2026)
  15. 5.3.5 Middle East and Africa Veterinary Antibacterial Prescription Drugs Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 China Animal Health And Resource
  2. 6.1.1 China Animal Health And Resource Company Information
  3. 6.1.2 China Animal Health And Resource Business Overview
  4. 6.1.3 China Animal Health And Resource Veterinary Antibacterial Prescription Drugs Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 China Animal Health And Resource Veterinary Antibacterial Prescription Drugs Product Portfolio
  6. 6.1.5 China Animal Health And Resource Recent Developments
  7. 6.2 Zoetis
  8. 6.2.1 Zoetis Company Information
  9. 6.2.2 Zoetis Business Overview
  10. 6.2.3 Zoetis Veterinary Antibacterial Prescription Drugs Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Zoetis Veterinary Antibacterial Prescription Drugs Product Portfolio
  12. 6.2.5 Zoetis Recent Developments
  13. 6.3 Shandong Lukang Shelile Pharmaceutical
  14. 6.3.1 Shandong Lukang Shelile Pharmaceutical Company Information
  15. 6.3.2 Shandong Lukang Shelile Pharmaceutical Business Overview
  16. 6.3.3 Shandong Lukang Shelile Pharmaceutical Veterinary Antibacterial Prescription Drugs Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Shandong Lukang Shelile Pharmaceutical Veterinary Antibacterial Prescription Drugs Product Portfolio
  18. 6.3.5 Shandong Lukang Shelile Pharmaceutical Recent Developments
  19. 6.4 Ripud Biotech
  20. 6.4.1 Ripud Biotech Company Information
  21. 6.4.2 Ripud Biotech Business Overview
  22. 6.4.3 Ripud Biotech Veterinary Antibacterial Prescription Drugs Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Ripud Biotech Veterinary Antibacterial Prescription Drugs Product Portfolio
  24. 6.4.5 Ripud Biotech Recent Developments
  25. 6.5 Qilu Pharmaceutical
  26. 6.5.1 Qilu Pharmaceutical Company Information
  27. 6.5.2 Qilu Pharmaceutical Business Overview
  28. 6.5.3 Qilu Pharmaceutical Veterinary Antibacterial Prescription Drugs Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Qilu Pharmaceutical Veterinary Antibacterial Prescription Drugs Product Portfolio
  30. 6.5.5 Qilu Pharmaceutical Recent Developments
  31. 6.6 North China Pharmaceutical
  32. 6.6.1 North China Pharmaceutical Company Information
  33. 6.6.2 North China Pharmaceutical Business Overview
  34. 6.6.3 North China Pharmaceutical Veterinary Antibacterial Prescription Drugs Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 North China Pharmaceutical Veterinary Antibacterial Prescription Drugs Product Portfolio
  36. 6.6.5 North China Pharmaceutical Recent Developments
  37. 6.7 Dalian Sanyi Animal Pharmaceutical
  38. 6.7.1 Dalian Sanyi Animal Pharmaceutical Company Information
  39. 6.7.2 Dalian Sanyi Animal Pharmaceutical Business Overview
  40. 6.7.3 Dalian Sanyi Animal Pharmaceutical Veterinary Antibacterial Prescription Drugs Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Dalian Sanyi Animal Pharmaceutical Veterinary Antibacterial Prescription Drugs Product Portfolio
  42. 6.7.5 Dalian Sanyi Animal Pharmaceutical Recent Developments
  43. 6.8 ZyVet
  44. 6.8.1 ZyVet Company Information
  45. 6.8.2 ZyVet Business Overview
  46. 6.8.3 ZyVet Veterinary Antibacterial Prescription Drugs Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 ZyVet Veterinary Antibacterial Prescription Drugs Product Portfolio
  48. 6.8.5 ZyVet Recent Developments
  49. 6.9 Virbac
  50. 6.9.1 Virbac Company Information
  51. 6.9.2 Virbac Business Overview
  52. 6.9.3 Virbac Veterinary Antibacterial Prescription Drugs Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Virbac Veterinary Antibacterial Prescription Drugs Product Portfolio
  54. 6.9.5 Virbac Recent Developments
  55. 6.10 Vetoquinol
  56. 6.10.1 Vetoquinol Company Information
  57. 6.10.2 Vetoquinol Business Overview
  58. 6.10.3 Vetoquinol Veterinary Antibacterial Prescription Drugs Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Vetoquinol Veterinary Antibacterial Prescription Drugs Product Portfolio
  60. 6.10.5 Vetoquinol Recent Developments
  61. 6.11 Randolph And Scott
  62. 6.11.1 Randolph And Scott Company Information
  63. 6.11.2 Randolph And Scott Business Overview
  64. 6.11.3 Randolph And Scott Veterinary Antibacterial Prescription Drugs Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Randolph And Scott Veterinary Antibacterial Prescription Drugs Product Portfolio
  66. 6.11.5 Randolph And Scott Recent Developments
  67. 6.12 Pharmaq
  68. 6.12.1 Pharmaq Company Information
  69. 6.12.2 Pharmaq Business Overview
  70. 6.12.3 Pharmaq Veterinary Antibacterial Prescription Drugs Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Pharmaq Veterinary Antibacterial Prescription Drugs Product Portfolio
  72. 6.12.5 Pharmaq Recent Developments
  73. 6.13 PetMed Express
  74. 6.13.1 PetMed Express Company Information
  75. 6.13.2 PetMed Express Business Overview
  76. 6.13.3 PetMed Express Veterinary Antibacterial Prescription Drugs Sales, Revenue and Gross Margin (2021-2026)
  77. 6.13.4 PetMed Express Veterinary Antibacterial Prescription Drugs Product Portfolio
  78. 6.13.5 PetMed Express Recent Developments
  79. 6.14 Norbrook Laboratories
  80. 6.14.1 Norbrook Laboratories Company Information
  81. 6.14.2 Norbrook Laboratories Business Overview
  82. 6.14.3 Norbrook Laboratories Veterinary Antibacterial Prescription Drugs Sales, Revenue and Gross Margin (2021-2026)
  83. 6.14.4 Norbrook Laboratories Veterinary Antibacterial Prescription Drugs Product Portfolio
  84. 6.14.5 Norbrook Laboratories Recent Developments
  85. 6.15 Merial
  86. 6.15.1 Merial Company Information
  87. 6.15.2 Merial Business Overview
  88. 6.15.3 Merial Veterinary Antibacterial Prescription Drugs Sales, Revenue and Gross Margin (2021-2026)
  89. 6.15.4 Merial Veterinary Antibacterial Prescription Drugs Product Portfolio
  90. 6.15.5 Merial Recent Developments
  91. 6.16 Merck Animal Health
  92. 6.16.1 Merck Animal Health Company Information
  93. 6.16.2 Merck Animal Health Business Overview
  94. 6.16.3 Merck Animal Health Veterinary Antibacterial Prescription Drugs Sales, Revenue and Gross Margin (2021-2026)
  95. 6.16.4 Merck Animal Health Veterinary Antibacterial Prescription Drugs Product Portfolio
  96. 6.16.5 Merck Animal Health Recent Developments
  97. 6.17 Heska
  98. 6.17.1 Heska Company Information
  99. 6.17.2 Heska Business Overview
  100. 6.17.3 Heska Veterinary Antibacterial Prescription Drugs Sales, Revenue and Gross Margin (2021-2026)
  101. 6.17.4 Heska Veterinary Antibacterial Prescription Drugs Product Portfolio
  102. 6.17.5 Heska Recent Developments
  103. 6.18 Elanco Animal Health
  104. 6.18.1 Elanco Animal Health Company Information
  105. 6.18.2 Elanco Animal Health Business Overview
  106. 6.18.3 Elanco Animal Health Veterinary Antibacterial Prescription Drugs Sales, Revenue and Gross Margin (2021-2026)
  107. 6.18.4 Elanco Animal Health Veterinary Antibacterial Prescription Drugs Product Portfolio
  108. 6.18.5 Elanco Animal Health Recent Developments
  109. 6.19 Dechra Pharmaceuticals
  110. 6.19.1 Dechra Pharmaceuticals Company Information
  111. 6.19.2 Dechra Pharmaceuticals Business Overview
  112. 6.19.3 Dechra Pharmaceuticals Veterinary Antibacterial Prescription Drugs Sales, Revenue and Gross Margin (2021-2026)
  113. 6.19.4 Dechra Pharmaceuticals Veterinary Antibacterial Prescription Drugs Product Portfolio
  114. 6.19.5 Dechra Pharmaceuticals Recent Developments
  115. 6.20 Ceva Sante Animale
  116. 6.20.1 Ceva Sante Animale Company Information
  117. 6.20.2 Ceva Sante Animale Business Overview
  118. 6.20.3 Ceva Sante Animale Veterinary Antibacterial Prescription Drugs Sales, Revenue and Gross Margin (2021-2026)
  119. 6.20.4 Ceva Sante Animale Veterinary Antibacterial Prescription Drugs Product Portfolio
  120. 6.20.5 Ceva Sante Animale Recent Developments
  121. 6.21 Boehringer Ingelheim Animal Health
  122. 6.21.1 Boehringer Ingelheim Animal Health Company Information
  123. 6.21.2 Boehringer Ingelheim Animal Health Business Overview
  124. 6.21.3 Boehringer Ingelheim Animal Health Veterinary Antibacterial Prescription Drugs Sales, Revenue and Gross Margin (2021-2026)
  125. 6.21.4 Boehringer Ingelheim Animal Health Veterinary Antibacterial Prescription Drugs Product Portfolio
  126. 6.21.5 Boehringer Ingelheim Animal Health Recent Developments
7 North America by Country
  1. 7.1 North America Veterinary Antibacterial Prescription Drugs Sales by Country
  2. 7.1.1 North America Veterinary Antibacterial Prescription Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Veterinary Antibacterial Prescription Drugs Sales by Country (2021-2026)
  4. 7.1.3 North America Veterinary Antibacterial Prescription Drugs Sales Forecast by Country (2027-2032)
  5. 7.2 North America Veterinary Antibacterial Prescription Drugs Market Size by Country
  6. 7.2.1 North America Veterinary Antibacterial Prescription Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Veterinary Antibacterial Prescription Drugs Market Size by Country (2021-2026)
  8. 7.2.3 North America Veterinary Antibacterial Prescription Drugs Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Veterinary Antibacterial Prescription Drugs Sales by Country
  2. 8.1.1 Europe Veterinary Antibacterial Prescription Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Veterinary Antibacterial Prescription Drugs Sales by Country (2021-2026)
  4. 8.1.3 Europe Veterinary Antibacterial Prescription Drugs Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Veterinary Antibacterial Prescription Drugs Market Size by Country
  6. 8.2.1 Europe Veterinary Antibacterial Prescription Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Veterinary Antibacterial Prescription Drugs Market Size by Country (2021-2026)
  8. 8.2.3 Europe Veterinary Antibacterial Prescription Drugs Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Veterinary Antibacterial Prescription Drugs Sales by Country
  2. 9.1.1 Asia-Pacific Veterinary Antibacterial Prescription Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Veterinary Antibacterial Prescription Drugs Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Veterinary Antibacterial Prescription Drugs Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Veterinary Antibacterial Prescription Drugs Market Size by Country
  6. 9.2.1 Asia-Pacific Veterinary Antibacterial Prescription Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Veterinary Antibacterial Prescription Drugs Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Veterinary Antibacterial Prescription Drugs Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Veterinary Antibacterial Prescription Drugs Sales by Country
  2. 10.1.1 South America Veterinary Antibacterial Prescription Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Veterinary Antibacterial Prescription Drugs Sales by Country (2021-2026)
  4. 10.1.3 South America Veterinary Antibacterial Prescription Drugs Sales Forecast by Country (2027-2032)
  5. 10.2 South America Veterinary Antibacterial Prescription Drugs Market Size by Country
  6. 10.2.1 South America Veterinary Antibacterial Prescription Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Veterinary Antibacterial Prescription Drugs Market Size by Country (2021-2026)
  8. 10.2.3 South America Veterinary Antibacterial Prescription Drugs Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Veterinary Antibacterial Prescription Drugs Sales by Country
  2. 11.1.1 Middle East and Africa Veterinary Antibacterial Prescription Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Veterinary Antibacterial Prescription Drugs Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Veterinary Antibacterial Prescription Drugs Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Veterinary Antibacterial Prescription Drugs Market Size by Country
  6. 11.2.1 Middle East and Africa Veterinary Antibacterial Prescription Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Veterinary Antibacterial Prescription Drugs Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Veterinary Antibacterial Prescription Drugs Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Veterinary Antibacterial Prescription Drugs Value Chain Analysis
  2. 12.1.1 Veterinary Antibacterial Prescription Drugs Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Veterinary Antibacterial Prescription Drugs Production Mode & Process
  7. 12.2 Veterinary Antibacterial Prescription Drugs Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Veterinary Antibacterial Prescription Drugs Distributors
  10. 12.2.3 Veterinary Antibacterial Prescription Drugs Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research